FDA lets Lilly cite Jardiance heart data, shares jump

(Reuters) - U.S regulators said on Friday they would allow Eli Lilly and Co to state that its diabetes drug Jardiance reduces risk of death from heart problems, lifting company shares almost 3 percent and potentially giving a strong boost to the drug's future sales.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news